Unique ID issued by UMIN | UMIN000008986 |
---|---|
Receipt number | R000010269 |
Scientific Title | Effectiveness of preoperative use of noninvasive ventilation (NIV) in patients with living donor liver transplantation |
Date of disclosure of the study information | 2012/09/27 |
Last modified on | 2018/12/05 11:25:38 |
Effectiveness of preoperative use of noninvasive ventilation (NIV) in patients with living donor liver transplantation
Preoperative use of noninvasive ventilation for living donor liver transplantation
Effectiveness of preoperative use of noninvasive ventilation (NIV) in patients with living donor liver transplantation
Preoperative use of noninvasive ventilation for living donor liver transplantation
Japan |
Living donor liver transplantation
Pneumology | Hepato-biliary-pancreatic surgery |
Others
NO
We study whether preoperative use of NIV for living donor liver transplantation may improve preoperative arterial blood gas and pulmonary function. Patients enrolled are randomly assigned to receive either standard treatment or NIV.
Efficacy
Confirmatory
Pragmatic
Not applicable
1. arterial blood oxygen level
2. alveolar-arterial difference in partial pressure of oxygen
1. lung function testing (forced expiratory volume in one second (FEV1), FEV1/forced vital capacity, maximum mid-expiratory flow rate, respiratory muscle force)
2. preoperative chest X ray
3. postoperative arterial blood gas
4. postoperative pulmonary infection
5. postoperative death
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
2
Prevention
Device,equipment |
The patients receive NIV for 2 to 3 hours in the daytime. Pressure support is increased until the maximal level tolerated by the patients is reached.
The patients continue the current treatments.
20 | years-old | <= |
70 | years-old | >= |
Male and Female
1. Recipients of living donor liver transplantation.
2. Analysis of arterial blood gas reveals PaO2 as less than 60 mmHg or PaCO2 as more than 7.3 or analysis of nocturnal monitoring reveals PtCO2 more than 45 mmHg or SpO2 less than 90%.
1. recipients of emergency living donor liver transplantation
2. recipients of living donor liver retransplantation
3. Patients need to receive oxygen therapy or NIV therapy by analysis of arterial blood gas and nocturnal monitoring.
4. unstable asthma or mild chronic obstructive pulmonary disease (percent predicted FEV1)
5. pneumothorax within 6 months
6. patients complicated with chronic lung disease
7. patients complicated with acute infections.
8. patients received NIV
40
1st name | |
Middle name | |
Last name | Kazuo Chin |
Graduate School of Medicine, Kyoto University
Department of respiratory management and sleep control medicine
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto
075-751-3852
chink@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Satoshi Hamada |
Graduate School of Medicine, Kyoto University
Department of Respiratory Medicine
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto
075-751-3830
sh1124@kuhp.kyoto-u.ac.jp
Department of respiratory management and sleep control medicine, Graduate School of Medicine, Kyoto University
nothing
Self funding
NO
京都大学病院(京都府)
2012 | Year | 09 | Month | 27 | Day |
Unpublished
Terminated
2012 | Year | 09 | Month | 24 | Day |
2012 | Year | 10 | Month | 01 | Day |
2015 | Year | 10 | Month | 31 | Day |
2015 | Year | 10 | Month | 31 | Day |
2015 | Year | 10 | Month | 31 | Day |
2012 | Year | 09 | Month | 26 | Day |
2018 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010269